Prescriptions flagged as risky in new list
Published: Sat, Sep. 06, 2008 12:30AM
Modified Sat, Sep. 06, 2008 01:42AM
E-Mail
Print
tool name
closeWASHINGTON -- In an effort to better inform doctors and patients, the government on Friday began posting a list of prescription drugs under investigation for potential safety problems.
The first list names 20 medications and the potential concern for each. It provides no indication of how widespread or serious the problems might be, leading some consumer advocates to question its usefulness.
The list (http://tinyurl.com/5bu2om) includes Tykerb, a GlaxoSmithKline drug to treat breast cancer, and Tysabri, a drug made by Biogen Idec at its Research Triangle Park facility.
More Business
All rights reserved. This copyrighted material may not be published, broadcast or redistributed in any manner.
Get it all with convenient home delivery of The News & Observer.
Staff writer Alan M. Wolf
The News & Observer is pleased to be able to offer its users the opportunity to make comments and hold conversations online. However, the interactive nature of the internet makes it impracticable for our staff to monitor each and every posting.
Since The News & Observer does not control user submitted statements, we cannot promise that readers will not occasionally find offensive or inaccurate comments posted on our website. In addition, we remind anyone interested in making an online comment that responsibility for statements posted lies with the person submitting the comment, not The News and Observer.
If you find a comment offensive, clicking on the exclamation icon will flag the comment for review by the administrators, we are counting on the good judgment of all our readers to help us.
